3. Procedure details.
| Study | Group | Symptoms to PCI time (minute) | PCI without stenting (n (%)) | DES (n (%)) | BMS (n (%)) | 2‐Vessel disease (n (%)) | 3‐Vessel disease (n (%)) | Received PCI non‐culprit (n (%)) | DAPT | DAPT duration |
| CvLPRIT 2015 | Complete | 182 | NR | 141 (94) | NR | 119 (79.3) | 31 (20.7) | 139 (92.7) | Yes | NR |
| Culprit‐only | 159 | NR | 127 (87) | NR | 110 (75.3) | 36 (24.7) | 0 | |||
| Dambrink and Ghani 2010 | Complete | NR | 6 (7.5) | 18 (22.5) | 56 (70) | 60 (75) | 20 (25) | 48 (60) | Yes | 1 month |
| Culprit‐only | NR | 7 (17.1) | 7 (7.1) | 27 (66) | 33 (80.5) | 8 (19.5) | 0 | |||
| DANAMI‐3‐PRIMULTI 2015 | Complete | NR | 12 (3.8) | 298 (95) | 0 | NR | 97 (31) | 193 (61.5) | Yes | 1 year |
| Culprit‐only | NR | 18 (5.8) | 290 (92.7) | 0 | NR | 100 (32) | 0 | |||
| Estevez Loureiro 2014 | Complete | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Culprit‐only | NR | NR | NR | NR | NR | NR | NR | |||
| HELP AMI 2004 | Complete | 210 | 0 | 52 (100) | 0 | 36 (69) | 16 (30.8) | NR | Yes | 1 month |
| Culprit‐only | 236 | 0 | 17 (100) | 0 | 9 (53) | 8 (47) | NR | |||
| Politi 2009 | Complete | NR | NR | 11 (8.5) | NR | NR | 48 (37) | NR | NR | NR |
| Culprit‐only | NR | NR | 10 (12) | NR | NR | 21 (25) | NR | |||
| PRAGUE‐13 2015 | Complete | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Culprit‐only | NR | NR | NR | NR | NR | NR | NR | |||
| PRAMI 2013 | Complete | NR | 1 (< 1) | 147 (63) | 86 (37) | 143 (61.1) | 91 (39) | 223 (95.3) | Yes | 1 month |
| Culprit‐only | NR | 0 | 135 (58) | 96 (42) | 155 (67.1) | 76 (33) | 2 (1) | |||
| Zhang 2015 | Complete | 214 | 0 | 215 (100) | 0 | NR | NR | NR | NR | NR |
| Culprit‐only | 227 | 0 | 213 (100) | 0 | NR | NR | NR |
BMS: bare‐metal stent; DAPT: dual antiplatelet therapy; DES: drug‐eluting stent; n: number of participants; NR: not reported in the article; PCI: percutaneous coronary intervention.